These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18991635)

  • 1. Signalling inhibitors against Mycobacterium tuberculosis--early days of a new therapeutic concept in tuberculosis.
    Hegymegi-Barakonyi B; Székely R; Varga Z; Kiss R; Borbély G; Németh G; Bánhegyi P; Pató J; Greff Z; Horváth Z; Mészáros G; Marosfalvi J; Erōs D; Szántai-Kis C; Breza N; Garavaglia S; Perozzi S; Rizzi M; Hafenbradl D; Ko M; Av-Gay Y; Klebl BM; Orfi L; Kéri G
    Curr Med Chem; 2008; 15(26):2760-70. PubMed ID: 18991635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel drug discovery concept for tuberculosis: inhibition of bacterial and host cell signalling.
    Székely R; Wáczek F; Szabadkai I; Németh G; Hegymegi-Barakonyi B; Eros D; Szokol B; Pató J; Hafenbradl D; Satchell J; Saint-Joanis B; Cole ST; Orfi L; Klebl BM; Kéri G
    Immunol Lett; 2008 Mar; 116(2):225-31. PubMed ID: 18258308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective inhibitors of the essential kinase PknB and their potential as anti-mycobacterial agents.
    Lougheed KE; Osborne SA; Saxty B; Whalley D; Chapman T; Bouloc N; Chugh J; Nott TJ; Patel D; Spivey VL; Kettleborough CA; Bryans JS; Taylor DL; Smerdon SJ; Buxton RS
    Tuberculosis (Edinb); 2011 Jul; 91(4):277-86. PubMed ID: 21482481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Novel Inhibitors of Mycobacterium tuberculosis PknG Using Pharmacophore Based Virtual Screening, Docking, Molecular Dynamics Simulation, and Their Biological Evaluation.
    Singh N; Tiwari S; Srivastava KK; Siddiqi MI
    J Chem Inf Model; 2015 Jun; 55(6):1120-9. PubMed ID: 25965448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sclerotiorin inhibits protein kinase G from Mycobacterium tuberculosis and impairs mycobacterial growth in macrophages.
    Chen D; Ma S; He L; Yuan P; She Z; Lu Y
    Tuberculosis (Edinb); 2017 Mar; 103():37-43. PubMed ID: 28237032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leads for antitubercular compounds from kinase inhibitor library screens.
    Magnet S; Hartkoorn RC; Székely R; Pató J; Triccas JA; Schneider P; Szántai-Kis C; Orfi L; Chambon M; Banfi D; Bueno M; Turcatti G; Kéri G; Cole ST
    Tuberculosis (Edinb); 2010 Nov; 90(6):354-60. PubMed ID: 20934382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prospects for development of new antituberculous drugs].
    Tomioka H
    Kekkaku; 2002 Aug; 77(8):573-84. PubMed ID: 12235850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of glucosyl-3-phosphoglycerate phosphatase as a novel drug target against resistant strain of Mycobacterium tuberculosis (XDR1219) by using comparative metabolic pathway approach.
    Uddin R; Zahra NU; Azam SS
    Comput Biol Chem; 2019 Apr; 79():91-102. PubMed ID: 30743161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Silico Identification of Possible Inhibitors for Protein Kinase B (PknB) of
    Vieira TF; Martins FG; Moreira JP; Barbosa T; Sousa SF
    Molecules; 2021 Oct; 26(20):. PubMed ID: 34684743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipolytic enzymes inhibitors: A new way for antibacterial drugs discovery.
    Cavalier JF; Spilling CD; Durand T; Camoin L; Canaan S
    Eur J Med Chem; 2021 Jan; 209():112908. PubMed ID: 33071055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Overview on the Potential Antimycobacterial Agents Targeting Serine/Threonine Protein Kinases from Mycobacterium tuberculosis.
    Mori M; Sammartino JC; Costantino L; Gelain A; Meneghetti F; Villa S; Chiarelli LR
    Curr Top Med Chem; 2019; 19(9):646-661. PubMed ID: 30827246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimycobacterial activity of UDP-galactopyranose mutase inhibitors.
    Borrelli S; Zandberg WF; Mohan S; Ko M; Martinez-Gutierrez F; Partha SK; Sanders DA; Av-Gay Y; Pinto BM
    Int J Antimicrob Agents; 2010 Oct; 36(4):364-8. PubMed ID: 20678902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Novel Mycobacterial Inhibitors Against Mycobacterial Protein Kinase G.
    Kanehiro Y; Tomioka H; Pieters J; Tatano Y; Kim H; Iizasa H; Yoshiyama H
    Front Microbiol; 2018; 9():1517. PubMed ID: 30050511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel high throughput pooled shRNA screening identifies NQO1 as a potential drug target for host directed therapy for tuberculosis.
    Li Q; Karim AF; Ding X; Das B; Dobrowolski C; Gibson RM; Quiñones-Mateu ME; Karn J; Rojas RE
    Sci Rep; 2016 Jun; 6():27566. PubMed ID: 27297123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lead selection and characterization of antitubercular compounds using the Nested Chemical Library.
    Sipos A; Pató J; Székely R; Hartkoorn RC; Kékesi L; Őrfi L; Szántai-Kis C; Mikušová K; Svetlíková Z; Korduláková J; Nagaraja V; Godbole AA; Bush N; Collin F; Maxwell A; Cole ST; Kéri G
    Tuberculosis (Edinb); 2015 Jun; 95 Suppl 1():S200-6. PubMed ID: 25801335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Silico Screen and Structural Analysis Identifies Bacterial Kinase Inhibitors which Act with β-Lactams To Inhibit Mycobacterial Growth.
    Wlodarchak N; Teachout N; Beczkiewicz J; Procknow R; Schaenzer AJ; Satyshur K; Pavelka M; Zuercher W; Drewry D; Sauer JD; Striker R
    Mol Pharm; 2018 Nov; 15(11):5410-5426. PubMed ID: 30285456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soybean lectin induces autophagy through P2RX7 dependent activation of NF-κB-ROS pathway to kill intracellular mycobacteria.
    Mishra A; Behura A; Kumar A; Ghosh A; Naik L; Mawatwal S; Mohanty SS; Mishra A; Saha S; Bhutia SK; Singh R; Dhiman R
    Biochim Biophys Acta Gen Subj; 2021 Feb; 1865(2):129806. PubMed ID: 33253803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.